Literature DB >> 19254567

Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression.

Junwei Gao1, Juxing Chen, Maxwell Kramer, Hidekazu Tsukamoto, An-Sheng Zhang, Caroline A Enns.   

Abstract

The mechanisms that allow the body to sense iron levels in order to maintain iron homeostasis are unknown. Patients with the most common form of hereditary iron overload have mutations in the hereditary hemochromatosis protein HFE. They have lower levels of hepcidin than unaffected individuals. Hepcidin, a hepatic peptide hormone, negatively regulates iron efflux from the intestines into the blood. We report two hepatic cell lines, WIF-B cells and HepG2 cells transfected with HFE, where hepcidin expression responded to iron-loaded transferrin. The response was abolished when endogenous transferrin receptor 2 (TfR2) was suppressed or in primary hepatocytes lacking either functional TfR2 or HFE. Furthermore, transferrin-treated HepG2 cells transfected with HFE chimeras containing only the alpha3 and cytoplasmic domains could upregulate hepcidin expression. Since the HFE alpha3 domain interacts with TfR2, these results supported our finding that TfR2/HFE complex is required for transcriptional regulation of hepcidin by holo-Tf.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19254567      PMCID: PMC2673483          DOI: 10.1016/j.cmet.2009.01.010

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  56 in total

1.  A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors:  J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

2.  Involvement of a cAMP-responsive DNA element in mediating TRH responsiveness of the human thyrotropin alpha-subunit gene.

Authors:  D S Kim; S K Ahn; J H Yoon; S H Hong; K E Kim; R A Maurer; S D Park
Journal:  Mol Endocrinol       Date:  1994-04

Review 3.  Unusual MHC-like molecules: CD1, Fc receptor, the hemochromatosis gene product, and viral homologs.

Authors:  I A Wilson; P J Bjorkman
Journal:  Curr Opin Immunol       Date:  1998-02       Impact factor: 7.486

4.  Dual luminescence-based reporter gene assay for luciferase and beta-galactosidase.

Authors:  C S Martin; P A Wight; A Dobretsova; I Bronstein
Journal:  Biotechniques       Date:  1996-09       Impact factor: 1.993

Review 5.  Hereditary hemochromatosis: etiologic, pathologic, and clinical aspects.

Authors:  T H Bothwell; A P MacPhail
Journal:  Semin Hematol       Date:  1998-01       Impact factor: 3.851

6.  HFE gene knockout produces mouse model of hereditary hemochromatosis.

Authors:  X Y Zhou; S Tomatsu; R E Fleming; S Parkkila; A Waheed; J Jiang; Y Fei; E M Brunt; D A Ruddy; C E Prass; R C Schatzman; R O'Neill; R S Britton; B R Bacon; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

7.  The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression.

Authors:  J N Feder; Z Tsuchihashi; A Irrinki; V K Lee; F A Mapa; E Morikang; C E Prass; S M Starnes; R K Wolff; S Parkkila; W S Sly; R C Schatzman
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

8.  Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor.

Authors:  J A Lebrón; M J Bennett; D E Vaughn; A J Chirino; P M Snow; G A Mintier; J N Feder; P J Bjorkman
Journal:  Cell       Date:  1998-04-03       Impact factor: 41.582

9.  Enhanced Na+-dependent bile salt uptake by WIF-B cells, a rat hepatoma hybrid cell line, following growth in the presence of a physiological bile salt.

Authors:  E M Konieczko; A K Ralston; A R Crawford; S J Karpen; J M Crawford
Journal:  Hepatology       Date:  1998-01       Impact factor: 17.425

10.  The hereditary hemochromatosis protein, HFE, inhibits iron uptake via down-regulation of Zip14 in HepG2 cells.

Authors:  Junwei Gao; Ningning Zhao; Mitchell D Knutson; Caroline A Enns
Journal:  J Biol Chem       Date:  2008-06-04       Impact factor: 5.157

View more
  137 in total

1.  Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease.

Authors:  James E Nelson; Laura Wilson; Elizabeth M Brunt; Matthew M Yeh; David E Kleiner; Aynur Unalp-Arida; Kris V Kowdley
Journal:  Hepatology       Date:  2010-11-29       Impact factor: 17.425

Review 2.  Unraveling mechanisms regulating systemic iron homeostasis.

Authors:  Karin E Finberg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

Review 3.  Known and potential roles of transferrin in iron biology.

Authors:  Thomas Benedict Bartnikas
Journal:  Biometals       Date:  2012-08       Impact factor: 2.949

Review 4.  Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation.

Authors:  Chia Chi Sun; Valentina Vaja; Jodie L Babitt; Herbert Y Lin
Journal:  Am J Hematol       Date:  2012-01-31       Impact factor: 10.047

Review 5.  Iron homeostasis and the inflammatory response.

Authors:  Marianne Wessling-Resnick
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

Review 6.  Murine mutants in the study of systemic iron metabolism and its disorders: an update on recent advances.

Authors:  Thomas B Bartnikas; Mark D Fleming; Paul J Schmidt
Journal:  Biochim Biophys Acta       Date:  2012-01-28

Review 7.  Hepcidin and iron homeostasis.

Authors:  Tomas Ganz; Elizabeta Nemeth
Journal:  Biochim Biophys Acta       Date:  2012-01-26

Review 8.  Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia.

Authors:  Sara Gardenghi; Robert W Grady; Stefano Rivella
Journal:  Hematol Oncol Clin North Am       Date:  2010-10-15       Impact factor: 3.722

Review 9.  Modulation of hepcidin as therapy for primary and secondary iron overload disorders: preclinical models and approaches.

Authors:  Paul J Schmidt; Mark D Fleming
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

Review 10.  A systems biology approach to iron metabolism.

Authors:  Julia Chifman; Reinhard Laubenbacher; Suzy V Torti
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.